Abstract
A 22-year-old female patient with severe hypertension underwent both Technetium-99m diethylenetriaminepentaacetate and Technetium-99m mercaptoacetyltriglycine basal and captopril renal scintigraphy. While no significant change was seen with Tc-99m DTPA, there was left sided parenchymal retention of captopril Tc-99m MAG3 suggesting renal artery stenosis which was confirmed by angiography.
Similar content being viewed by others
References
Majd M, Potter BM, Guzzetta PC, Ruley EJ. Effect of captopril on efficacy of renal scintigraphy in detection of renal artery stenosis.J Nucl Med 1983; 24:23–28.
Sfakianakis GN, Bourgoigne JJ, Jaffe D, Kyriakides G, Perez-Stable E, Duncan RC. Single dose captopril scintigraphy in the diagnosis of renovascular hypertension.J Nucl Med 1987; 28: 1383–1392.
Uĝur Ö, Caner B, Çekirge S, Balkanci F, Ergun EL, Kostakoglu L, et al. The diagnosis of renovascular hypertension with technetium 99m ethylenedicysteine captopril scintigraphy.Investigative Radiology 1996; 31: 497–501.
Taylor AT Jr, Fletcher JW, Nally JV Jr, Blaufox MD, Dubovsky EV, Fine EJ, et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine.J Nucl Med 1998; 39: 1297–1302.
Nally JV Jr, Chen C, Fine EJ, Fommei E, Ghione S, Geykes GG, et al. Diagnosis criteria of renovascular hypertension with captopril renography; A consensus statement.Am J Hypertension 1991; 4: 749–752.
Sfakianakis GN, Vonorta K, Zilleruelo G, et al. Scintigraphy in acquired renal disorders. InNuclear Medicine Annual, Freeman LM (ed), New York; Raven Press, 1992: 157–224.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiratli, P.Ö., Caner, B., Altun, B. et al. Superiority of Tc-99m MAG3 to Tc-99m DTPA in treating a patient with mild renal artery stenosis. Ann Nucl Med 15, 45–48 (2001). https://doi.org/10.1007/BF03012130
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03012130